Walgreens reports that patients approached by its clinical trials unit are 20% more likely to enroll in studies compared to traditional referral methods. Since launching its trials business in 2022, Walgreens has engaged over 17 million individuals, emphasizing community-based recruitment and representation of underserved groups, including older adults and historically underrepresented populations. Collaborations with pharma partners like AstraZeneca enhance their mobile recruitment efforts, expanding trial accessibility and patient diversity.